Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Regeneron's Flagship Drug Treats Blindness In Seniors
Investors.com
Friday, April 12, 2013 - 9:56am
tags:
Regeneron, age-related macular degeneration, Eylea
Amyris rises on Sanofi malaria drug news
Yahoo/AP
Friday, April 12, 2013 - 9:55am
tags:
artemisinin, Amyris, malaria, Sanofi
Alkermes Announces Restructuring Plan
Yahoo/Zacks
Friday, April 12, 2013 - 9:52am
tags:
restructuring, Alkermes
MannKind's Afrezza Likely To Fail AFFINITY 1 Phase III Trial
Seeking Alpha
Friday, April 12, 2013 - 9:51am
tags:
MannKind, Afrezza, diabetes, inhaled insulin
Warner Chilcott Announces FDA Approval of DORYX(R) Delayed-Release 200 mg Tablets
Yahoo
Friday, April 12, 2013 - 9:49am
tags:
Warner Chilcott, FDA, DORYX, antiobiotics
Is Celgene's Apremilast A Potential Blockbuster Or Not?
Seeking Alpha
Friday, April 12, 2013 - 9:48am
tags:
Celgene, apremilast, AbbVie, Amgen, JNJ, Humira, Stelara, psoriasis, Enbrel
Forbes Earnings Preview: Johnson & Johnson
Forbes
Thursday, April 11, 2013 - 4:37pm
tags:
earnings, JNJ
Drugmaker Lilly plans cuts to US sales force
Yahoo/AP
Thursday, April 11, 2013 - 4:37pm
tags:
drug reps, layoffs, Eli Lilly
Study: Pharma Reps Don't Tell Docs About Side Effects
Pharma Live
Thursday, April 11, 2013 - 4:07pm
tags:
physicians, side effects, drug reps
[video]Pharma Companies ‘Entering a New Era’: Eli Lilly CEO
CNBC
Thursday, April 11, 2013 - 12:39pm
tags:
John Lechleiter, GSK, Pharma CEOs, R&D
Valeant, Actavis team up on two more authorized generics
Fierce Pharma
Thursday, April 11, 2013 - 12:37pm
tags:
Actavis, generics, Valeant Pharmaceuticals, Cordran Tape, Zovirax
Dara Biosciences: Don't Believe The Hype Surrounding This Biopharma
Seeking Alpha
Thursday, April 11, 2013 - 12:32pm
tags:
DARA Biosciences
Risk plan change not enough for Vivus drug success: top investor
Reuters
Thursday, April 11, 2013 - 11:51am
tags:
Vivus, Qsymia, obesity
Affymax says considering all alternatives, including bankruptcy
Yahoo/Fly on the Wall
Thursday, April 11, 2013 - 11:49am
tags:
bankruptcy, Affymax
3 Biotechs With Upcoming Product Launches
Seeking Alpha
Thursday, April 11, 2013 - 11:48am
tags:
drug launches, Surfaxin, Discovery Labs, respiratory distress syndrome, Adasuve, Alexza, NuPathe, migraines, Zecuity, antipsychotics
Acadia Gets Expedited FDA Review Path for Lead Drug
Bloomberg
Thursday, April 11, 2013 - 11:40am
tags:
Acadia, FDA, pimavanserin, Parkinson's Disease
Roche First-Quarter Revenue Rises on U.S. Tamiflu Sales
Bloomberg
Thursday, April 11, 2013 - 11:37am
tags:
earnings, Roche
Gamida Cell to meet FDA, EMA over stem cell treatment
Reuters
Thursday, April 11, 2013 - 11:37am
tags:
FDA, Gamida Cell, stem cells, StemEx
Biodel: Reemerging From Obscurity In 2013
Seeking Alpha
Thursday, April 11, 2013 - 11:34am
tags:
Biodel, Eli Lilly, BIOD-123, recombinant human insulin, BIOD-250
Muscular Dystrophy Drug Succeeds, Sarepta Buyers Flood In
Seeking Alpha
Thursday, April 11, 2013 - 11:33am
tags:
Duchenne Muscular Dystrophy, Sarepta, GSK, eteplirsen, drisapersen, Prosensa

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.